These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2916986

  • 1. Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog.
    Filep J, Hermán F, Braquet P, Mózes T.
    Biochem Biophys Res Commun; 1989 Jan 31; 158(2):353-9. PubMed ID: 2916986
    [Abstract] [Full Text] [Related]

  • 2. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock.
    Mózes T, Braquet P, Filep J.
    Am J Physiol; 1989 Oct 31; 257(4 Pt 2):R872-7. PubMed ID: 2802004
    [Abstract] [Full Text] [Related]

  • 3. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
    Filep JG, Braquet P, Mózes T.
    Circ Shock; 1991 Sep 31; 35(1):1-8. PubMed ID: 1742856
    [Abstract] [Full Text] [Related]

  • 4. Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF).
    Sagach VF, Dmitrieva AV, Braquet P.
    Lipids; 1991 Dec 31; 26(12):1400-3. PubMed ID: 1819740
    [Abstract] [Full Text] [Related]

  • 5. Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat.
    Filep J, Hermán F, Braquet P.
    Lipids; 1991 Dec 31; 26(12):1356-8. PubMed ID: 1819733
    [Abstract] [Full Text] [Related]

  • 6. Significance of platelet-activating factor in mesenteric ischemia-reperfusion.
    Filep J, Braquet P, Mózes T.
    Lipids; 1991 Dec 31; 26(12):1336-9. PubMed ID: 1819728
    [Abstract] [Full Text] [Related]

  • 7. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
    Mózes T, Heiligers JP, Tak CJ, Zijlstra FJ, Ben-Efraim S, Saxena PR, Bonta IL.
    J Lipid Mediat; 1991 Nov 31; 4(3):309-25. PubMed ID: 1764577
    [Abstract] [Full Text] [Related]

  • 8. The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation.
    Wainwright CL, Parratt JR, Bigaud M.
    Biomed Biochim Acta; 1988 Nov 31; 47(10-11):S224-7. PubMed ID: 3248108
    [Abstract] [Full Text] [Related]

  • 9. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
    Riera M, Torras J, Herrero I, Valles J, Paubert-Braquet M, Cruzado JM, Alsina J, Grinyo JM.
    J Pharmacol Exp Ther; 1997 Feb 31; 280(2):786-94. PubMed ID: 9023292
    [Abstract] [Full Text] [Related]

  • 10. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists.
    Lagente V, Fortes ZB, Garcia-Leme J, Vargaftig BB.
    J Pharmacol Exp Ther; 1988 Oct 31; 247(1):254-61. PubMed ID: 3171975
    [Abstract] [Full Text] [Related]

  • 11. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG, Sirois MG, Rousseau A, Fournier A, Sirois P.
    Br J Pharmacol; 1991 Dec 31; 104(4):797-804. PubMed ID: 1667286
    [Abstract] [Full Text] [Related]

  • 12. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.
    Filep JG, Hermán F, Földes-Filep E, Schneider F, Braquet P.
    Br J Pharmacol; 1992 Apr 31; 105(4):912-8. PubMed ID: 1324056
    [Abstract] [Full Text] [Related]

  • 13. [The role of the thrombocyte-activating factor in the development of circulatory disorders in the postischemic shock reaction].
    Sagach VF, Dmitrieva AV.
    Fiziol Zh (1978); 1990 Apr 31; 36(4):8-14. PubMed ID: 2172032
    [Abstract] [Full Text] [Related]

  • 14. Histamine potentiates human platelet aggregation induced by platelet-activating factor.
    Sipka S, Koltai M, Braquet P, Szegedi G.
    Int Arch Allergy Immunol; 1992 Apr 31; 97(1):89-92. PubMed ID: 1582704
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs.
    Maruyama M, Farber NE, Vercellotti GM, Jacob HS, Gross GJ.
    Am Heart J; 1990 Sep 31; 120(3):510-20. PubMed ID: 2389687
    [Abstract] [Full Text] [Related]

  • 16. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils.
    Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P.
    Prostaglandins; 1987 Sep 31; 34(3):337-49. PubMed ID: 3432553
    [Abstract] [Full Text] [Related]

  • 17. Superoxide dismutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion.
    Droy-Lefaix MT, Drouet Y, Geraud G, Hosford D, Braquet P.
    Free Radic Res Commun; 1991 Sep 31; 12-13 Pt 2():725-35. PubMed ID: 2060844
    [Abstract] [Full Text] [Related]

  • 18. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence.
    Kubes P, Ibbotson G, Russell J, Wallace JL, Granger DN.
    Am J Physiol; 1990 Aug 31; 259(2 Pt 1):G300-5. PubMed ID: 2166441
    [Abstract] [Full Text] [Related]

  • 19. Endotoxin shock, kinin system and PAF-acether in the rat.
    Damas J, Remacle-Volon G, Adam A, Bourdon V.
    Adv Exp Med Biol; 1989 Aug 31; 247B():547-52. PubMed ID: 2610092
    [No Abstract] [Full Text] [Related]

  • 20. Effects of antioxidants and PAF receptor antagonist in intestinal shock in the rat.
    Haglind E, Xia G, Rylander R.
    Circ Shock; 1994 Feb 31; 42(2):83-91. PubMed ID: 8013065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.